2,224 Shares in CME Group Inc. (NASDAQ:CME) Bought by Inscription Capital LLC

Inscription Capital LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,224 shares of the financial services provider’s stock, valued at approximately $590,000.

Several other large investors also recently bought and sold shares of the company. New Age Alpha Advisors LLC grew its holdings in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after buying an additional 43 shares during the last quarter. Knuff & Co LLC acquired a new stake in shares of CME Group during the fourth quarter valued at $33,000. Banque Transatlantique SA purchased a new stake in CME Group during the 4th quarter worth about $35,000. Whipplewood Advisors LLC purchased a new stake in CME Group during the 4th quarter worth about $37,000. Finally, United Community Bank acquired a new position in CME Group in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director now owns 3,668 shares of the company’s stock, valued at $1,035,916.56. This trade represents a 12.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the business’s stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares in the company, valued at approximately $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Royal Bank Of Canada restated a “sector perform” rating and set a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Morgan Stanley increased their target price on CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research report on Thursday, April 24th. UBS Group raised their price target on CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, April 25th. Raymond James Financial raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective for the company in a research note on Monday, March 10th. Finally, Barclays increased their price objective on shares of CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $258.20.

CME Group Trading Up 0.8%

Shares of CME stock opened at $269.70 on Wednesday. The stock has a 50-day simple moving average of $273.29 and a 200 day simple moving average of $254.82. The stock has a market capitalization of $97.19 billion, a P/E ratio of 27.13, a P/E/G ratio of 3.63 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.50 earnings per share. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.85%. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.